Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Sandoz Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (682)
Cancellation by sponsor (321)
Prescription medicine registration (54)
Section 14, TGO91 consent (17)
Cancellation or suspension (8)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)

Date

2024 (82)
2023 (78)
2022 (67)
2021 (121)
2020 (153)
2019 (53)
2018 (60)
2017 (50)
2016 (4)
2015 (39)
2014 (20)
2013 (24)
2012 (13)
2011 (51)
2010 (47)
2009 (37)
2008 (27)
2007 (21)
2006 (21)
2005 (54)
2004 (12)
2003 (10)
2002 (10)
2001 (6)
2000 (5)
1999 (5)
1998 (9)
1997 (4)
1991 (3)

Results for "[search-keyword]"

Search

Sponsor content

1087 result(s) found, displaying 641 to 650

SANDOZ COLD & FLU PE DAY AND NIGHT tablets blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Sandoz Pty Ltd
DICLOFENAC AN diclofenac sodium 25mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Sandoz Pty Ltd
DICLOFENAC AN diclofenac sodium 50mg enteric-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Sandoz Pty Ltd
AMOXYCLAV GH 875/125 amoxicillin 875mg (as trihydrate) & clavulanic acid 125mg (as potassium) tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Sandoz Pty Ltd
Capecitabine Sandoz capecitabine 500mg film coated tablet bottle Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Sandoz Pty Ltd
Capecitabine Sandoz capecitabine 150mg film coated tablet bottle Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Sandoz Pty Ltd
GLIMEPIRIDE SANDOZ glimepiride 4 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Sandoz Pty Ltd
RISPERISAN risperidone 4mg film-coated tablet in blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Sandoz Pty Ltd
LAMOTRIGINE SZ lamotrigine 25 mg Dispersible/Chewable tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Sandoz Pty Ltd
LAMOTRIGINE SZ lamotrigine 50 mg Dispersible/Chewable tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Sandoz Pty Ltd

Pages

First page
Previous page
…
Page 61
Page 62
Page 63
Page 64
Current page 65
Page 66
Page 67
Page 68
Page 69
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.